A Role for Brain Stress Systems in Addiction

[1]  G. Koob,et al.  The α1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration , 2009, Pharmacology Biochemistry and Behavior.

[2]  G. Koob,et al.  Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinking , 2008, Pharmacology Biochemistry and Behavior.

[3]  G. Koob,et al.  α1-Noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access , 2008, European Neuropsychopharmacology.

[4]  N. Murphy,et al.  Endogenous Nociceptin (Orphanin FQ) Suppresses Basal Hedonic State and Acute Reward Responses to Methamphetamine and Ethanol, but Facilitates Chronic Responses , 2008, Neuropsychopharmacology.

[5]  G. Koob,et al.  alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. , 2008, Alcohol.

[6]  K. Lutfy,et al.  The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine , 2008, Neuropharmacology.

[7]  G. Koob,et al.  MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist , 2008, Pharmacology Biochemistry and Behavior.

[8]  G. Koob,et al.  Pharmacological Evidence for a Motivational Role of κ-Opioid Systems in Ethanol Dependence , 2008, Neuropsychopharmacology.

[9]  G. Koob,et al.  CRF1 receptor antagonists attenuate escalated cocaine self-administration in rats , 2008, Psychopharmacology.

[10]  P. Hipskind,et al.  Upregulation of Voluntary Alcohol Intake, Behavioral Sensitivity to Stress, and Amygdala Crhr1 Expression Following a History of Dependence , 2008, Biological Psychiatry.

[11]  Martin H. Schmidt,et al.  Interaction between CRHR1 Gene and Stressful Life Events Predicts Adolescent Heavy Alcohol Use , 2008, Biological Psychiatry.

[12]  M. Le Moal,et al.  Addiction and the brain antireward system. , 2008, Annual review of psychology.

[13]  Julia C. Lemos,et al.  The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System , 2008, The Journal of Neuroscience.

[14]  南部 忠洋.  Distribution of orexin neurons in the adult rat brain , 2007 .

[15]  A. Bruijnzeel,et al.  Effects of the CRF receptor antagonist d-Phe CRF(12–41) and the α2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats , 2007, Neuropharmacology.

[16]  G. Valdez,et al.  κ Agonist-Induced Reinstatement of Cocaine Seeking in Squirrel Monkeys: A Role for Opioid and Stress-Related Mechanisms , 2007, Journal of Pharmacology and Experimental Therapeutics.

[17]  V. Chefer,et al.  Dynorphin and the pathophysiology of drug addiction. , 2007, Pharmacology & therapeutics.

[18]  L. Parsons,et al.  CRF–CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats , 2007, Proceedings of the National Academy of Sciences.

[19]  G. Koob,et al.  Stress, dysregulation of drug reward pathways, and the transition to drug dependence. , 2007, The American journal of psychiatry.

[20]  V. Molina,et al.  Lack of feedback inhibition on rat basolateral amygdala following stress or withdrawal from sedative‐hypnotic drugs , 2007, The European journal of neuroscience.

[21]  E. V. Bockstaele,et al.  Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. , 2007, Progress in neuro-psychopharmacology & biological psychiatry.

[22]  G. Koob,et al.  A CRF2 agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats , 2007, Brain Research.

[23]  G. Calo’,et al.  Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice , 2007, Peptides.

[24]  G. Koob,et al.  Viral vector-induced amygdala NPY overexpression reverses increased alcohol intake caused by repeated deprivations in Wistar rats. , 2007, Brain : a journal of neurology.

[25]  R. Wise,et al.  Stress-induced relapse to cocaine seeking: roles for the CRF2 receptor and CRF-binding protein in the ventral tegmental area of the rat , 2007, Psychopharmacology.

[26]  Danielle L. Graham,et al.  Region‐specific tolerance to cocaine‐regulated cAMP‐dependent protein phosphorylation following chronic self‐administration , 2007, The European journal of neuroscience.

[27]  G. Bakalkin,et al.  The Nociceptin/Orphanin FQ Receptor Agonist Ro 64-6198 Reduces Alcohol Self-Administration and Prevents Relapse-Like Alcohol Drinking , 2007, Neuropsychopharmacology.

[28]  G. Tsujimoto,et al.  Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice , 2007, Behavioural Brain Research.

[29]  P. Hipskind,et al.  3-(4-Chloro-2-Morpholin-4-yl-Thiazol-5-yl)-8-(1-Ethylpropyl)-2,6-Dimethyl-Imidazo[1,2-b]Pyridazine: A Novel Brain-Penetrant, Orally Available Corticotropin-Releasing Factor Receptor 1 Antagonist with Efficacy in Animal Models of Alcoholism , 2007, The Journal of Neuroscience.

[30]  G. Koob,et al.  ‘Nicotine deprivation effect' in rats with intermittent 23-hour access to intravenous nicotine self-administration , 2007, Pharmacology Biochemistry and Behavior.

[31]  M. Gold,et al.  The effects of buprenorphine on fentanyl withdrawal in rats , 2007, Psychopharmacology.

[32]  G. Koob,et al.  Corticotropin-Releasing Factor 1 Antagonists Selectively Reduce Ethanol Self-Administration in Ethanol-Dependent Rats , 2007, Biological Psychiatry.

[33]  D. Economidou,et al.  Effect of novel nociceptin/orphanin FQ–NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats , 2006, Peptides.

[34]  Antonio Alcaro,et al.  Ethanol consumption and reward depend on norepinephrine in the prefrontal cortex , 2006, Neuroreport.

[35]  M. Heilig.  Faculty Opinions recommendation of Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. , 2006 .

[36]  G. Koob,et al.  Corticotropin-Releasing Factor within the Central Nucleus of the Amygdala Mediates Enhanced Ethanol Self-Administration in Withdrawn, Ethanol-Dependent Rats , 2006, The Journal of Neuroscience.

[37]  A. C. Hansson,et al.  Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress , 2006, Proceedings of the National Academy of Sciences.

[38]  G. Aston-Jones,et al.  Arousal and reward: a dichotomy in orexin function , 2006, Trends in Neurosciences.

[39]  D. Winder,et al.  Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis , 2006, Neuropharmacology.

[40]  C. Cifani,et al.  Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats , 2006, Peptides.

[41]  G. Siggins,et al.  Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Griebel,et al.  Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats , 2006, Psychopharmacology.

[43]  Peter S. B. Finnie,et al.  A role for corticotropin-releasing factor, but not corticosterone, in acute food-deprivation-induced reinstatement of heroin seeking in rats , 2006, Psychopharmacology.

[44]  Steven P. Wilson,et al.  Overexpression of neuropeptide Y in the central nucleus of the amygdala decreases ethanol self-administration in "anxious" rats. , 2006, Alcoholism, clinical and experimental research.

[45]  T. Renda,et al.  Changes in neuropeptide FF and NPY immunohistochemical patterns in rat brain under heroin treatment , 2006, Brain Research.

[46]  G. Koob,et al.  Escalation of methamphetamine self-administration in rats: a dose–effect function , 2006, Psychopharmacology.

[47]  Lin Lu,et al.  Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats , 2006, Psychopharmacology.

[48]  R. Dantzer.  The roles of vasopressin and oxytocin in memory processing, Barbara McEwen. Elsevier Academic Press, San Diego (2004), (p. 740, ISBN 0-12-03295-4) , 2006 .

[49]  C. Ferris,et al.  Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior , 2006, Pharmacology Biochemistry and Behavior.

[50]  S. Shioda,et al.  Direct Involvement of Orexinergic Systems in the Activation of the Mesolimbic Dopamine Pathway and Related Behaviors Induced by Morphine , 2006, The Journal of Neuroscience.

[51]  Donald W. Pfaff,et al.  Brain Arousal and Information Theory: Neural and Genetic Mechanisms , 2005 .

[52]  G. Koob,et al.  Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  F. Papaleo,et al.  The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  G. Koob,et al.  The Neurobiology of Addiction , 1997, Alcohol health and research world.

[55]  G. Koob,et al.  Plasticity of reward neurocircuitry and the 'dark side' of drug addiction , 2005, Nature Neuroscience.

[56]  E. Nestler.  Is there a common molecular pathway for addiction? , 2005, Nature Neuroscience.

[57]  Mark S. Gold,et al.  The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence , 2005, Brain Research Reviews.

[58]  Joseph E LeDoux,et al.  Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior , 2005, Neuron.

[59]  S. Pandey,et al.  Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. , 2005, The Journal of clinical investigation.

[60]  James L. Howard,et al.  Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats , 2005, Psychopharmacology.

[61]  G. Aston-Jones,et al.  A role for lateral hypothalamic orexin neurons in reward seeking , 2005, Nature.

[62]  N. Maidment,et al.  The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference , 2005, Neuropharmacology.

[63]  D. Overstreet,et al.  Prior Multiple Ethanol Withdrawals Enhance Stress-Induced Anxiety-Like Behavior: Inhibition by CRF1- and Benzodiazepine-Receptor Antagonists and a 5-HT1a-Receptor Agonist , 2005, Neuropsychopharmacology.

[64]  Jonathan D. Cohen,et al.  An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. , 2005, Annual review of neuroscience.

[65]  C. Ehlers,et al.  Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure , 2005, Behavioural Brain Research.

[66]  F. Simonin,et al.  Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. , 2005, Alcoholism, clinical and experimental research.

[67]  Y. Shaham,et al.  Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats , 2005, Psychopharmacology.

[68]  P. Veinante,et al.  Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala , 2005, Science.

[69]  R. Blakely,et al.  Norepinephrine Modulates Glutamatergic Transmission in the Bed Nucleus of the Stria Terminalis , 2005, Neuropsychopharmacology.

[70]  R. Rimondini,et al.  Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence , 2005, Neuroscience Letters.

[71]  C. McClung,et al.  DeltaFosB: a molecular switch for long-term adaptation in the brain. , 2004, Brain research. Molecular brain research.

[72]  Takeshi Sakurai,et al.  Interaction between the Corticotropin-Releasing Factor System and Hypocretins (Orexins): A Novel Circuit Mediating Stress Response , 2004, The Journal of Neuroscience.

[73]  G. Koob,et al.  Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism , 2004, Pharmacology Biochemistry and Behavior.

[74]  L. Parsons,et al.  Increased GABA Release in the Central Amygdala of Ethanol-Dependent Rats , 2004, The Journal of Neuroscience.

[75]  G. Koob,et al.  Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. , 2004, Alcoholism, clinical and experimental research.

[76]  Stephen C. Heinrichs,et al.  Corticotropin-Releasing Factor in Brain: A Role in Activation, Arousal, and Affect Regulation , 2004, Journal of Pharmacology and Experimental Therapeutics.

[77]  E. V. Van Bockstaele,et al.  Chronic Morphine Sensitizes the Brain Norepinephrine System to Corticotropin-Releasing Factor and Stress , 2004, The Journal of Neuroscience.

[78]  John T. Williams,et al.  Noradrenaline Triggers GABAA Inhibition of Bed Nucleus of the Stria Terminalis Neurons Projecting to the Ventral Tegmental Area , 2004, The Journal of Neuroscience.

[79]  D. R. Sparta,et al.  Peripheral and central administration of a selective neuropeptide Y Y1 receptor antagonist suppresses ethanol intake by C57BL/6J mice. , 2004, Alcoholism, clinical and experimental research.

[80]  M. Heilig.  The NPY system in stress, anxiety and depression , 2004, Neuropeptides.

[81]  Ting-kai Li,et al.  Reduced neuropeptide Y mRNA expression in the central nucleus of amygdala of alcohol preferring (P) rats: its potential involvement in alcohol preference and anxiety , 2004, Brain Research.

[82]  G. Koob,et al.  The therapeutic potential of CRF1 antagonists for anxiety , 2004, Expert opinion on investigational drugs.

[83]  P. Ernfors,et al.  Assessment of ethanol consumption and water drinking by NPY Y2 receptor knockout mice , 2004, Peptides.

[84]  G. Koob,et al.  Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation. , 2004, Alcoholism, clinical and experimental research.

[85]  V. Neugebauer,et al.  The Amygdala and Persistent Pain , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[86]  Y. Ueta,et al.  Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons , 2004, Regulatory Peptides.

[87]  M. Patil,et al.  Behavioral / Systems / Cognitive Corticotrophin Releasing Factor-Induced Synaptic Plasticity in the Amygdala Translates Stress into Emotional Disorders , 2004 .

[88]  R. Spealman,et al.  Pharmacological Blockade of α2-Adrenoceptors Induces Reinstatement of Cocaine-Seeking Behavior in Squirrel Monkeys , 2004, Neuropsychopharmacology.

[89]  S. D. Moore,et al.  Ethanol Augments GABAergic Transmission in the Central Amygdala via CRF1 Receptors , 2004, Science.

[90]  D. Economidou,et al.  Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats , 2004, Psychopharmacology.

[91]  N. Murphy,et al.  Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice , 2004, Psychopharmacology.

[92]  D. Overstreet,et al.  Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors , 2004, Pharmacology Biochemistry and Behavior.

[93]  D. Overstreet,et al.  SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. , 2004, Alcohol.

[94]  J. Maeda,et al.  Nicotine withdrawal induces subsensitivity of hypothalamic–pituitary–adrenal axis to stress in rats: implications for precipitation of depression during smoking cessation , 2004, Psychoneuroendocrinology.

[95]  W. Vale,et al.  CRF and CRF receptors: role in stress responsivity and other behaviors. , 2004, Annual review of pharmacology and toxicology.

[96]  M. Todtenkopf,et al.  Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats , 2004, Psychopharmacology.

[97]  A. Kelley,et al.  Activation of a subpopulation of orexin/hypocretin‐containing hypothalamic neurons by GABAA receptor‐mediated inhibition of the nucleus accumbens shell, but not by exposure to a novel environment , 2004, The European journal of neuroscience.

[98]  R. Woo,et al.  Orphanin FQ/nociceptin blocks methamphetamine place preference in rats , 2003, Neuroreport.

[99]  Elyssa B. Margolis,et al.  κ-Opioid Agonists Directly Inhibit Midbrain Dopaminergic Neurons , 2003, The Journal of Neuroscience.

[100]  A. Kelley,et al.  Overlapping distributions of orexin/hypocretin‐ and dopamine‐β‐hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress , 2003, The Journal of comparative neurology.

[101]  J. Moreau,et al.  Impact of environmental housing conditions on the emotional responses of mice deficient for nociceptin/orphanin FQ peptide precursor gene , 2003, Behavioural Brain Research.

[102]  S. Matta,et al.  Norepinephrine release in amygdala of rats during chronic nicotine self-administration: an in vivo microdialysis study , 2003, Neuropharmacology.

[103]  J. Silberring,et al.  Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats. , 2003, European journal of pharmacology.

[104]  G. Koob,et al.  Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist , 2003, Brain Research.

[105]  Lin Lu,et al.  Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review , 2003, Neuroscience & Biobehavioral Reviews.

[106]  C. Chavkin,et al.  κ Opioid Receptor Antagonism and Prodynorphin Gene Disruption Block Stress-Induced Behavioral Responses , 2003, The Journal of Neuroscience.

[107]  Y. Shaham,et al.  The reinstatement model of drug relapse: history, methodology and major findings , 2003, Psychopharmacology.

[108]  J. Murphy,et al.  Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats. , 2003, Alcoholism, clinical and experimental research.

[109]  D. Economidou,et al.  The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats , 2003, Physiology & Behavior.

[110]  T. Nakagawa,et al.  Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats , 2003, Psychopharmacology.

[111]  Ting-kai Li,et al.  Neuropeptide Y reduces oral ethanol intake in alcohol-preferring (P) rats following a period of imposed ethanol abstinence. , 2003, Alcoholism, clinical and experimental research.

[112]  S. File,et al.  Corticotropin releasing factor antagonist, α-helical CRF9–41, reverses nicotine-induced conditioned, but not unconditioned, anxiety , 2003, Psychopharmacology.

[113]  S. D. Moore,et al.  Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[114]  G. Koob,et al.  Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. , 2003, Alcohol.

[115]  L. Terenius,et al.  Acquisition, Expression, and Reinstatement of Ethanol-Induced Conditioned Place Preference in Mice: Effects of Opioid Receptor-Like 1 Receptor Agonists and Naloxone , 2003, Journal of Pharmacology and Experimental Therapeutics.

[116]  Eric J. Nestler,et al.  Inhibition of cAMP Response Element-Binding Protein or Dynorphin in the Nucleus Accumbens Produces an Antidepressant-Like Effect , 2002, The Journal of Neuroscience.

[117]  R. Rimondini,et al.  Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats , 2002, Neuroscience Letters.

[118]  G. Koob,et al.  Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat , 2002, Brain Research.

[119]  G. Koob,et al.  Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. , 2002, Alcoholism, clinical and experimental research.

[120]  F. Weiss,et al.  Additive Effect of Stress and Drug Cues on Reinstatement of Ethanol Seeking: Exacerbation by History of Dependence and Role of Concurrent Activation of Corticotropin-Releasing Factor and Opioid Mechanisms , 2002, The Journal of Neuroscience.

[121]  P. Fletcher,et al.  The Role of Corticotropin-Releasing Factor in the Median Raphe Nucleus in Relapse to Alcohol , 2002, The Journal of Neuroscience.

[122]  G. Koob,et al.  Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide , 2002, Brain Research.

[123]  T. Bolwig,et al.  Ethanol withdrawal in rats is attenuated by intracerebroventricular administration of neuropeptide Y. , 2002, Alcohol and alcoholism.

[124]  F. Leri,et al.  Blockade of Stress-Induced But Not Cocaine-Induced Reinstatement by Infusion of Noradrenergic Antagonists into the Bed Nucleus of the Stria Terminalis or the Central Nucleus of the Amygdala , 2002, The Journal of Neuroscience.

[125]  N. Goeders.  Stress and cocaine addiction. , 2002, The Journal of pharmacology and experimental therapeutics.

[126]  S. Pandey,et al.  The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. , 2002, Alcoholism, clinical and experimental research.

[127]  C. Hodge,et al.  Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake , 2002, Pharmacology Biochemistry and Behavior.

[128]  J. Sutcliffe,et al.  The hypocretins: Setting the arousal threshold , 2002, Nature Reviews Neuroscience.

[129]  M. Barrot,et al.  Regional and Cellular Mapping of cAMP Response Element-Mediated Transcription during Naltrexone-Precipitated Morphine Withdrawal , 2002, The Journal of Neuroscience.

[130]  J. Silberring,et al.  Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference , 2002, Behavioural pharmacology.

[131]  G. Griebel,et al.  Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[132]  J. Moreau,et al.  The orphanin receptor agonist RO 64-6198 does not induce place conditioning in rats , 2002, Neuroreport.

[133]  R. Ciccocioppo,et al.  Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198 , 2002, Psychopharmacology.

[134]  G. Koob,et al.  Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat , 2002, Psychopharmacology.

[135]  M. T. Koh,et al.  Voluntary Alcohol Consumption Is Controlled via the Neuropeptide Y Y1 Receptor , 2002, The Journal of Neuroscience.

[136]  R. Quirion,et al.  Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[137]  R. Rimondini,et al.  Long‐lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[138]  X. Wang,et al.  Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. , 2001, European journal of pharmacology.

[139]  S. Matta,et al.  Norepinephrine Secretion in the Hypothalamic Paraventricular Nucleus of Rats during Unlimited Access to Self-Administered Nicotine: An In Vivo Microdialysis Study , 2001, The Journal of Neuroscience.

[140]  C. Hara,et al.  Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system. , 2001, European journal of pharmacology.

[141]  S. Salvadori,et al.  Endogenous nociceptin signaling and stress-induced analgesia , 2001, Neuroreport.

[142]  M. Wilson,et al.  Neurotrophin-3 modulates noradrenergic neuron function and opiate withdrawal , 2001, Molecular Psychiatry.

[143]  C. Donaldson,et al.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[144]  R. Pabst,et al.  Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety , 2001, Neuroscience.

[145]  M. Le Moal,et al.  Progressive Enhancement of Delayed Hyperalgesia Induced by Repeated Heroin Administration: A Sensitization Process , 2001, The Journal of Neuroscience.

[146]  L. Parsons,et al.  Compulsive Drug‐Seeking Behavior and Relapse , 2001 .

[147]  D. Woldbye,et al.  Inhibitory effect of neuropeptide Y on morphine withdrawal is accompanied by reduced c‐fos expression in specific brain regions , 2001, Journal of neuroscience research.

[148]  F. Weiss,et al.  Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats , 2001, Neuroreport.

[149]  Lin Lu,et al.  Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats. , 2001, European journal of pharmacology.

[150]  D. Myers,et al.  Stereotaxic delivery of corticosterone to the amygdala modulates colonic sensitivity in rats , 2001, Brain Research.

[151]  T. Li,et al.  Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats. , 2001, Alcoholism, clinical and experimental research.

[152]  J. Vaughan,et al.  Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[153]  H. Akil,et al.  Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic–hypothalamic–pituitary–adrenal axis , 2001, Neuroscience.

[154]  G. Koob,et al.  Drug Addiction, Dysregulation of Reward, and Allostasis , 2001, Neuropsychopharmacology.

[155]  N. Maidment,et al.  Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats , 2001, Psychopharmacology.

[156]  S. Erb,et al.  A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats , 2001, Psychopharmacology.

[157]  J. B. Justice,et al.  κ-Opioid Receptor Activation Modifies Dopamine Uptake in the Nucleus Accumbens and Opposes the Effects of Cocaine , 2000, The Journal of Neuroscience.

[158]  R. Spanagel,et al.  Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats , 2000, Psychopharmacology.

[159]  C. Wilkinson,et al.  Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. , 2000, Alcoholism, clinical and experimental research.

[160]  J. Franck,et al.  Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain. , 2000, Alcohol.

[161]  F. Weiss,et al.  Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. , 2000, European journal of pharmacology.

[162]  A. Pol.  Narcolepsy A Neurodegenerative Disease of the Hypocretin System? , 2000, Neuron.

[163]  Jane Stewart,et al.  Stress-induced relapse to heroin and cocaine seeking in rats: a review , 2000, Brain Research Reviews.

[164]  Y. Shaham,et al.  Alpha-2 Adrenergic Receptor Agonists Block Stress-Induced Reinstatement of Cocaine Seeking , 2000, Neuropsychopharmacology.

[165]  K. Gysling,et al.  Chronic Morphine Treatment and Withdrawal Increase Extracellular Levels of Norepinephrine in the Rat Bed Nucleus of the Stria Terminalis , 2000, Journal of neurochemistry.

[166]  G. Koob,et al.  Dissociation of Locomotor Activation and Suppression of Food Intake Induced by CRF in CRFR1-Deficient Mice. , 2000, Endocrinology.

[167]  F. Weiss,et al.  Nociceptin prevents stress‐induced ethanol‐but not cocaine‐seeking behavior in rats , 2000, Neuroreport.

[168]  Y. Shaham,et al.  The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats , 2000, Psychopharmacology.

[169]  C. Heyser,et al.  Excessive Ethanol Drinking Following a History of Dependence: Animal Model of Allostasis , 2000, Neuropsychopharmacology.

[170]  Y. Shaham,et al.  Involvement of the medial septum in stress‐induced relapse to heroin seeking in rats , 2000, The European journal of neuroscience.

[171]  Nicole C. Rust,et al.  Ethanol-Associated Behaviors of Mice Lacking Norepinephrine , 2000, The Journal of Neuroscience.

[172]  G. Adam,et al.  A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[173]  K. Barron,et al.  Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior , 2000, Brain Research.

[174]  G. Koob,et al.  Persistent Increase in the Motivation to Take Heroin in Rats with a History of Drug Escalation , 2000, Neuropsychopharmacology.

[175]  J S Fowler,et al.  Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. , 2000, Cerebral cortex.

[176]  G. Aston-Jones,et al.  Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion , 2000, Nature.

[177]  G. Koob,et al.  A role for corticotropin releasing factor and urocortin in behavioral responses to stressors , 1999, Brain Research.

[178]  G. Koob,et al.  Corticotropin-releasing factor, norepinephrine, and stress , 1999, Biological Psychiatry.

[179]  S. Erb,et al.  A Role for the Bed Nucleus of the Stria Terminalis, But Not the Amygdala, in the Effects of Corticotropin-Releasing Factor on Stress-Induced Reinstatement of Cocaine Seeking , 1999, The Journal of Neuroscience.

[180]  H. Akil,et al.  Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: Evidence for their selective activation by interleukin‐1β , 1999, The Journal of comparative neurology.

[181]  A. Loizzo,et al.  Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats , 1999, Neuroscience Letters.

[182]  J. Moreau,et al.  Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[183]  Emmanuel Mignot,et al.  The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.

[184]  G. Koob,et al.  Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. , 1999, The Journal of pharmacology and experimental therapeutics.

[185]  Jon T. Willie,et al.  Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.

[186]  G. Koob,et al.  Corticotropin-releasing factor antagonist attenuates the “anxiogenic-like” effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats , 1999, Psychopharmacology.

[187]  F Weiss,et al.  In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self‐administering rats , 1999, Synapse.

[188]  J. Radulovic,et al.  Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2 , 1999, The Journal of Neuroscience.

[189]  G. Aston-Jones,et al.  The Bed Nucleus of the Stria Terminalis: A Target Site for Noradrenergic Actions in Opiate Withdrawal , 1999, Annals of the New York Academy of Sciences.

[190]  V. Chefer,et al.  Modulation of Cocaine‐induced Sensitization by κ‐Opioid Receptor Agonists: Role of the Nucleus Accumbens and Medial Prefrontal Cortex , 1999, Annals of the New York Academy of Sciences.

[191]  C. Ehlers,et al.  Innate differences of neuropeptide Y (NPY) in hypothalamic nuclei and central nucleus of the amygdala between selectively bred rats with high and low alcohol preference. , 1999, Alcoholism, clinical and experimental research.

[192]  S. Chaki,et al.  Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. , 1999, The Journal of pharmacology and experimental therapeutics.

[193]  S. Watson,et al.  Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat , 1999, The Journal of comparative neurology.

[194]  H. Herzog,et al.  Regional distribution of Y‐receptor subtype mRNAs in rat brain , 1999, The European journal of neuroscience.

[195]  A. Shekhar,et al.  Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses , 1999, Behavioural Brain Research.

[196]  D. Gehlert,et al.  Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. , 1999, European journal of pharmacology.

[197]  K. Gysling,et al.  Noradrenaline inhibits glutamate release in the rat bed nucleus of the stria terminalis: In vivo microdialysis studies , 1999, Journal of neuroscience research.

[198]  C. Ehlers,et al.  Neurophysiological effects of intracerebroventricular administration of urocortin , 1999, Peptides.

[199]  Y. Hurd,et al.  A heroin-, but not a cocaine-expecting, self-administration state preferentially alters endogenous brain peptides. , 1999, European journal of pharmacology.

[200]  A. N. van den Pol,et al.  Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems , 1998, The Journal of Neuroscience.

[201]  R. Palmiter,et al.  Ethanol consumption and resistance are inversely related to neuropeptide Y levels , 1998, Nature.

[202]  G. Koob,et al.  Clonidine Blocks Acquisition But not Expression of Conditioned Opiate Withdrawal in Rats , 1998, Neuropsychopharmacology.

[203]  C. Ehlers,et al.  Neuropeptide Y levels in ethanol-naive alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure. , 1998, Alcoholism, clinical and experimental research.

[204]  G F Koob,et al.  Transition from moderate to excessive drug intake: change in hedonic set point. , 1998, Science.

[205]  E. V. Van Bockstaele,et al.  Amygdaloid Corticotropin‐Releasing Factor Targets Locus Coeruleus Dendrites: Substrate for the Co‐ordination of Emotional and Cognitive Limbs of the Stress Response , 1998, Journal of neuroendocrinology.

[206]  J. Harro,et al.  Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats , 1998, Regulatory Peptides.

[207]  Y. Shaham,et al.  The Role of Corticotropin-Releasing Factor and Corticosterone in Stress- and Cocaine-Induced Relapse to Cocaine Seeking in Rats , 1998, The Journal of Neuroscience.

[208]  G. Koob,et al.  Nociceptin fails to affect heroin self‐administration in the rat , 1998, Neuroreport.

[209]  J. Hagan,et al.  The behavioural effects of corticotropin-releasing factor-related peptides in rats , 1998, Psychopharmacology.

[210]  G F Koob,et al.  Drug dependence: stress and dysregulation of brain reward pathways. , 1998, Drug and alcohol dependence.

[211]  D. Grandy,et al.  Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more , 1998, Trends in Neurosciences.

[212]  Y. Shaham,et al.  CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats , 1998, Psychopharmacology.

[213]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[214]  T. Madsen,et al.  Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors. , 1998, The Journal of pharmacology and experimental therapeutics.

[215]  F. Monsma,et al.  Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[216]  P. Piazza,et al.  Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications , 1997, Brain Research Reviews.

[217]  F. Guimarães,et al.  Anxiogenic effect of corticotropin‐releasing hormone in the dorsal periaqueductal grey , 1997, Neuroreport.

[218]  G F Koob,et al.  Drug abuse: hedonic homeostatic dysregulation. , 1997, Science.

[219]  T. Baram,et al.  The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist , 1997, Brain Research.

[220]  Younglim Lee,et al.  Role of the Hippocampus, the Bed Nucleus of the Stria Terminalis, and the Amygdala in the Excitatory Effect of Corticotropin-Releasing Hormone on the Acoustic Startle Reflex , 1997, The Journal of Neuroscience.

[221]  P. Veinante,et al.  Distribution of oxytocin‐ and vasopressin‐binding sites in the rat extended amygdala: a histoautoradiographic study , 1997, The Journal of comparative neurology.

[222]  G. Koob,et al.  Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. , 1997, Science.

[223]  Gavin Kilpatrick,et al.  Urocortin, a novel neuropeptide with anxiogenic‐like properties , 1997, Neuroreport.

[224]  A. Turnbull,et al.  Corticotropin-Releasing Factor (CRF) and Endocrine Responses to Stress: CRF Receptors, Binding Protein, and Related Peptides , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[225]  N. Goeders.  A neuroendocrine role in cocaine reinforcement , 1997, Psychoneuroendocrinology.

[226]  Y. Shaham,et al.  Corticotropin-Releasing Factor, But Not Corticosterone, Is Involved in Stress-Induced Relapse to Heroin-Seeking in Rats , 1997, The Journal of Neuroscience.

[227]  B. Budziszewska,et al.  Effects of single and repeated morphine administration on the prodynorphin, proenkephalin and dopamine D2 receptor gene expression in the mouse brain , 1997, Neuropeptides.

[228]  D. Grandy,et al.  Orphanin FQ is a functional anti-opioid peptide , 1996, Neuroscience.

[229]  Anne W. Schmidt,et al.  CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[230]  G. Koob,et al.  Appetite-Suppressing Effects of Urocortin, a CRF-Related Neuropeptide , 1996, Science.

[231]  N. Maidment,et al.  Intracerebroventricular orphanin FQ/Nociceptin supresses dopamine release in the nucleus accumbens of anaesthetized rats , 1996, Neuroscience.

[232]  F. Monsma,et al.  The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion , 1996, Brain Research.

[233]  C. Fahlke,et al.  Facilitation of ethanol consumption by intracerebroventricular infusions of corticosterone , 1996, Psychopharmacology.

[234]  B Anton,et al.  Immunohistochemical localization of ORL‐1 in the central nervous system of the rat , 1996, The Journal of comparative neurology.

[235]  E. Bizzi,et al.  The Cognitive Neurosciences , 1996 .

[236]  D. Grandy,et al.  Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor , 1995, Science.

[237]  M. Heilig.  Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding , 1995, Regulatory Peptides.

[238]  Marc Parmentier,et al.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor , 1995, Nature.

[239]  G. Koob,et al.  Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[240]  S. D. Glick,et al.  Kappa opioid inhibition of morphine and cocaine self-administration in rats , 1995, Brain Research.

[241]  Z. Sarnyai,et al.  Brain corticotropin-releasing factor mediates ‘anxiety-like’ behavior induced by cocaine withdrawal in rats , 1995, Brain Research.

[242]  J M Besson,et al.  Spino (trigemino) parabrachiohypothalamic pathway: electrophysiological evidence for an involvement in pain processes. , 1995, Journal of neurophysiology.

[243]  G. Koob,et al.  Suppression of corticotropin‐releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal , 1995, Behavioural pharmacology.

[244]  Michael Davis,et al.  Neurotransmission in the rat amygdala related to fear and anxiety , 1994, Trends in Neurosciences.

[245]  G. Koob,et al.  Corticotropin-releasing factor and neuropeptide y: role in emotional integration , 1994, Trends in Neurosciences.

[246]  G. Aghajanian,et al.  Molecular and cellular mechanisms of opiate action: Studies in the rat locus coeruleus , 1994, Brain Research Bulletin.

[247]  Bruce S. McEwen,et al.  Allostasis, amygdala, and anticipatory angst , 1994, Neuroscience & Biobehavioral Reviews.

[248]  M. Kreek,et al.  Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. , 1994, Neuroreport.

[249]  J. Schulkin,et al.  Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus , 1994, Brain Research.

[250]  G Vassart,et al.  ORL1, a novel member of the opioid receptor family , 1994, FEBS letters.

[251]  M. Le Moal,et al.  Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[252]  N. Kalin,et al.  Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat , 1993, Brain Research.

[253]  S. Foote,et al.  The Locus Coeruleus as a Site for Integrating Corticotropin‐Releasing Factor and Noradrenergic Mediation of Stress Responses a , 1993, Annals of the New York Academy of Sciences.

[254]  M. Kreek,et al.  'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. , 1993, Brain research. Molecular brain research.

[255]  S. Matta,et al.  Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization. , 1993, Endocrinology.

[256]  G. Koob,et al.  Anxiolytic-Like Action of Neuropeptide Y: Mediation by Y1 Receptors in Amygdala, and Dissociation from Food Intake Effects , 1993, Neuropsychopharmacology.

[257]  J. Daunais,et al.  Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. , 1993, Neuroreport.

[258]  G. Koob,et al.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal , 1993, Brain Research.

[259]  A. Takemori,et al.  Stimulation by corticotropin-releasing factor of the release of immunoreactive dynorphin A from mouse spinal cords in vitro. , 1992, European journal of pharmacology.

[260]  T. Kameyama,et al.  Systemic administration of dynorphin A(1–13) markedly inhibits different behavioural responses induced by cocaine in the mouse , 1992, Neuropharmacology.

[261]  N. Kalin,et al.  Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats , 1992, Brain Research.

[262]  A. K. Rattan,et al.  The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1–13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat , 1992, Brain Research.

[263]  K. Gulya,et al.  Chronic ethanol ingestion decreases vasopressin mRNA in hypothalamic and extrahypothalamic nuclei of mouse brain , 1991, Brain Research.

[264]  P. Sawchenko,et al.  Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[265]  Z. Han,et al.  [Bed nucleus of the stria terminalis]. , 1990, Sheng li ke xue jin zhan [Progress in physiology].

[266]  H. Takagi,et al.  Substance P afferents have synaptic contacts with dopaminergic neurons in the ventral tegmental area of the rat , 1990, Neuroscience Letters.

[267]  J. Besson,et al.  The spino(trigemino)pontoamygdaloid pathway: electrophysiological evidence for an involvement in pain processes. , 1990 .

[268]  P. Butler,et al.  Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[269]  L. Swanson,et al.  Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat , 1989, The Journal of comparative neurology.

[270]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[271]  B. Tabakoff,et al.  Receptors with V1 characteristics mediate the maintenance of ethanol tolerance by vasopressin. , 1988, The Journal of pharmacology and experimental therapeutics.

[272]  J. T. Reason,et al.  Handbook of Life Stress, Cognition and Health , 1988 .

[273]  G. Di Chiara,et al.  Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[274]  I. Assenmacher,et al.  Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin releasing hormone and vasopressin in rats , 1986, Brain Research.

[275]  H. Emrich,et al.  Psychotomimesis mediated by kappa opiate receptors , 1986, Science.

[276]  J. Fallon,et al.  Distribution of dynorphin and enkephalin peptides in the rat brain , 1986, The Journal of comparative neurology.

[277]  M. E. Lewis,et al.  Anatomy of the CNS opioid systems , 1985, Trends in Neurosciences.

[278]  J. Jolles,et al.  Vasopressin and related peptides: Animal and human studies , 1985, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[279]  J. Crabbe,et al.  Vasopressin and ethanol preference. II. Altered preference in two strains of diabetes insipidus rats and nephrogenic diabetes insipidus mice , 1985, Peptides.

[280]  J. Morley,et al.  Neuropeptide Y: A potent inducer of consummatory behavior in rats , 1984, Peptides.

[281]  D. Wied,et al.  Differential behavioral actions of corticotropin-releasing factor (CRF) , 1984, Pharmacology Biochemistry and Behavior.

[282]  P S Kalra,et al.  Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. , 1984, Endocrinology.

[283]  T. Crow,et al.  Neuropeptide Y distribution in human brain , 1983, Nature.

[284]  James E. Moore.  Arginine vasopressin enhances retention of morphine tolerance , 1983, Pharmacology Biochemistry and Behavior.

[285]  W. Kostowski,et al.  Further studies on the role of noradrenergic mechanisms in ethanol withdrawal syndrome in rats. , 1983, Polish journal of pharmacology and pharmacy.

[286]  H. Akil,et al.  Comparison of the distribution of dynorphin systems and enkephalin systems in brain. , 1982, Science.

[287]  C. Chavkin,et al.  Dynorphin is a specific endogenous ligand of the κ opioid receptor Science, 215 (1982) 413–415 , 1982, Pain.

[288]  G. Koob,et al.  Corticotropin releasing factor produces behavioural activation in rats , 1982, Nature.

[289]  C. Chavkin,et al.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor. , 1982, Science.

[290]  F. Bloom,et al.  Vasopressor receptor antagonist prevents behavioural effects of vasopressin , 1981, Nature.

[291]  S. Burchfield.  The Stress Response: A New Perspective , 1979, Psychosomatic medicine.

[292]  T. E. Werner,et al.  Reinforcement with intragastric infusions of ethanol: Blocking effect of FLA 57 , 1979, Pharmacology Biochemistry and Behavior.

[293]  S. T. Mason,et al.  Noradrenaline and ethanol intake in the rat , 1979, Neuroscience Letters.

[294]  R. Ritzmann,et al.  Arginine vasopressin maintains ethanol tolerance , 1978, Nature.

[295]  S. Sparber,et al.  Clonidine antagonizes naloxone-induced suppression of conditioned behavior and body weight loss in morphine-dependent rats , 1978, Pharmacology Biochemistry and Behavior.

[296]  S. Ogren,et al.  Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine-beta-hydroxylase inhibition. , 1977, Archives internationales de pharmacodynamie et de therapie.

[297]  Z. Amit,et al.  The effects of selective catecholamine depletions by 6-hydroxydopamine on ethanol preference in rats , 1977, Neuroscience Letters.

[298]  R. Solomon,et al.  An opponent-process theory of motivation. I. Temporal dynamics of affect. , 1974, Psychological review.

[299]  J. Knott.  The organization of behavior: A neuropsychological theory , 1951 .

[300]  C. Himmelsbach.  STUDIES ON THE RELATION OF DRUG ADDICTION TO THE AUTONOMIC NERVOUS SYSTEM: RESULTS OF COLD PRESSOR TESTS , 1941 .

[301]  H. Selye.  A Syndrome produced by Diverse Nocuous Agents , 1936, Nature.

[302]  F. Leri,et al.  Involvement of Arginine Vasopressin and V1b Receptor in Heroin Withdrawal and Heroin Seeking Precipitated by Stress and by Heroin , 2008, Neuropsychopharmacology.

[303]  G. Koob,et al.  Buprenorphine and a CRF1 Antagonist Block the Acquisition of Opiate Withdrawal-Induced Conditioned Place Aversion in Rats , 2005, Neuropsychopharmacology.

[304]  G. Koob,et al.  CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat , 2005, Psychopharmacology.

[305]  G. Aston-Jones,et al.  β-adrenergic antagonists attenuate withdrawal anxiety in cocaine-and morphine-dependent rats , 2005, Psychopharmacology.

[306]  G. Koob.  Allostatic view of motivation: implications for psychopathology. , 2004, Nebraska Symposium on Motivation. Nebraska Symposium on Motivation.

[307]  J. Felger,et al.  Nociceptin/Orphanin FQ Increases Anxiety-Related Behavior and Circulating Levels of Corticosterone During Neophobic Tests of Anxiety , 2004, Neuropsychopharmacology.

[308]  K. Liang,et al.  Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats , 2004, Psychopharmacology.

[309]  M. Heilig,et al.  Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models , 2004, Psychopharmacology.

[310]  A. Swiergiel.  Effects of infusion of corticotropin-releasing factor antagonist into the locus coeruleus on freezing behavior and brain catecholamines in rats. , 2003, Acta neurobiologiae experimentalis.

[311]  Markus Heilig,et al.  Brain neuropeptide Y (NPY) in stress and alcohol dependence. , 2002, Reviews in the neurosciences.

[312]  G. Koob,et al.  RECENT ADVANCES IN ANIMAL MODELS OF DRUG ADDICTION , 2002 .

[313]  Markus Heilig,et al.  Brain Neuropeptide Υ (NPY) in Stress and Alcohol Dependence , 2002 .

[314]  Dennis S. Charney,et al.  Neuropsychopharmacology : The Fifth Generation of Progress , 2002 .

[315]  L. Parsons,et al.  Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. , 2001, Annals of the New York Academy of Sciences.

[316]  M. Nijsen,et al.  CRH Signalling in the Bed Nucleus of the Stria Terminalis is Involved in Stress-Induced Cardiac Vagal Activation in Conscious Rats , 2001, Neuropsychopharmacology.

[317]  C. Polidori,et al.  Effect of nociceptin on alcohol intake in alcohol-preferring rats , 1999, Psychopharmacology.

[318]  M. Miller,et al.  Anatomy and function of extrahypothalamic vasopressin systems in the brain. , 1998, Progress in brain research.

[319]  E. Stein,et al.  Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study. , 1998, The Journal of pharmacology and experimental therapeutics.

[320]  B. Kobilka,et al.  Insights from in vivo modification of adrenergic receptor gene expression. , 1998, Annual review of pharmacology and toxicology.

[321]  S. Carr,et al.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. , 1998, Cell.

[322]  T. Robbins,et al.  Arousal systems and attention. , 1995 .

[323]  E. D. De Souza,et al.  Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. , 1995, Psychoneuroendocrinology.

[324]  G. Aston-Jones,et al.  Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. , 1993, Psychopharmacology.

[325]  R. Spanagel,et al.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[326]  L. Heimer,et al.  Piecing together the puzzle of basal forebrain anatomy. , 1991, Advances in experimental medicine and biology.

[327]  E. Sellers,et al.  Management of the alcohol withdrawal syndrome. , 1991, Annual review of medicine.

[328]  K. Grant,et al.  The role of arginine vasopressin in alcohol tolerance. , 1990, Annals of medicine.

[329]  P. Sterling,et al.  Allostasis: A new paradigm to explain arousal pathology. , 1988 .

[330]  J. de Vry,et al.  Effects of desglycinamide9, (Arg8) vasopressin and vasopressin antiserum on the acquisition of intravenous cocaine self-administration in the rat. , 1988, Life sciences.

[331]  G. Koob,et al.  Stimulant and anxiogenic effects of corticotropin releasing factor. , 1985, Progress in clinical and biological research.

[332]  L. Swanson,et al.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. , 1983, Neuroendocrinology.

[333]  M. Gold,et al.  Clonidine decreases opiate withdrawal-related anxiety: possible opiate noradrenergic interaction in anxiety and panic. , 1980, Substance and alcohol actions/misuse.

[334]  R. Solomon,et al.  An Opponent-Process Theory of Motivation , 1978 .

[335]  Stierlin.  Organization of Behavior. A Neuropsychological Theory , 1953 .